Kate E. Lines

Kate E. Lines

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Long-acting parathyroid hormone receptor agonist rectifies hypocalcemia in autosomal dominant hypocalcemia type 1 mice.

Journal: The Journal of clinical investigation

Published: February 19, 2026

Epigenetics and disease progression in neuroendocrine neoplasms.

Epigenetics and disease progression in neuroendocrine neoplasms.

Journal: Endocrine reviews

Published: September 02, 2025

Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice.

Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice.

Journal: The lancet. Diabetes & endocrinology

Published: December 23, 2024

Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis.

Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis.

Journal: The lancet. Diabetes & endocrinology

Published: December 23, 2024

NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.

NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.

Journal: Endocrine oncology (Bristol, England)

Published: September 10, 2024

Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.

Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.

Journal: International journal of cancer

Published: August 02, 2024

Characterization of quinazolinone calcilytic therapy for autosomal dominant hypocalcemia type 1 (ADH1).

Characterization of quinazolinone calcilytic therapy for autosomal dominant hypocalcemia type 1 (ADH1).

Journal: The Journal of biological chemistry

Published: June 21, 2024

Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers.

Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers.

Journal: Endocrine oncology (Bristol, England)

Published: May 23, 2024

Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes.

Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes.

Journal: JBMR plus

Published: January 17, 2024

Genetics of hereditary forms of primary hyperparathyroidism.

Genetics of hereditary forms of primary hyperparathyroidism.

Journal: Hormones (Athens, Greece)

Published: October 04, 2023

The role of DNA methylation in human pancreatic neuroendocrine tumours.

The role of DNA methylation in human pancreatic neuroendocrine tumours.

Journal: Endocrine oncology (Bristol, England)

Published: March 30, 2023

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer.

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer.

Journal: Oncogene

Published: March 24, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026